SHARE PURCHASE AGREEMENT among Kedrion S.p.A. as Purchaser -and- Liminal BioSciences Inc. as Seller dated May 14, 2021Share Purchase Agreement • May 21st, 2021 • Liminal BioSciences Inc. • Pharmaceutical preparations • Ontario
WHEREAS Seller is the beneficial and registered owner of one hundred percent (100%) of the issued and outstanding shares of Prometic Plasma Resources Inc. (“PPR Canada”) and Prometic Plasma Resources (USA) Inc. (“PPR USA” and together with PPR Canada, the ”Corporations”) and the beneficial and registered owner of one hundred percent (100%) of the issued and outstanding shares of Prometic Biotherapeutics Inc. (“PBT”) and Prometic Bioproduction Inc. (“PBP”, and together with PBT, the ”Ryplazim Targets”);
